Altab Shaikh
Hyderabad, TG 500007, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Pharmacokinetics and Biodistribution of Polymeric Nanoparticles Loaded with a Small Molecule Drug in Mice with Alcoholic Liver Disease.
Journal: Molecular pharmaceutics
Published: July 31, 2025
Tetrahydropyrimidine Ionizable Lipids for Efficient mRNA Delivery.
Journal: ACS nano
Published: October 11, 2024
Mitochondria-targeted esculetin and metformin delay endothelial senescence by promoting fatty acid β-oxidation: Relevance in age-associated atherosclerosis.
Journal: Mechanisms of ageing and development
Published: January 05, 2024
Correction to: Therapeutic efficacies of mitochondria‑targeted esculetin and metformin in the improvement of age‑associated atherosclerosis via regulating AMPK activation.
Journal: GeroScience
Published: December 25, 2023
Mitochondria targeted esculetin administration improves insulin resistance and hyperglycemia-induced atherosclerosis in db/db mice.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: November 14, 2023
Therapeutic efficacy of mitochondria-targeted esculetin in the improvement of NAFLD-NASH via modulating AMPK-SIRT1 axis.
Journal: International immunopharmacology
Published: August 01, 2023
Therapeutic efficacies of mitochondria-targeted esculetin and metformin in the improvement of age-associated atherosclerosis via regulating AMPK activation.
Journal: GeroScience
Published: June 23, 2023
A functional and self-assembling octyl-phosphonium-tagged esculetin as an effective siRNA delivery agent.
Journal: Chemical communications (Cambridge, England)
Published: November 05, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026